search
Back to results

Effects of Dualsite Anodic tDCS on Lower Limbs Function in Patients After Stroke: Randomized, Double-blind, Placebo-controlled, Crossover Trial

Primary Purpose

Stroke, Chronic

Status
Recruiting
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
Transcranial direct current stimulation (Anodal tDCS) + dual-task training
Transcranial direct current stimulation (tDCS dualsite) + dual-task traning
Transcranial direct current stimulation sham + dual-task training
Sponsored by
Federal University of Paraíba
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Stroke, Chronic focused on measuring Stroke, Transcranial direct current stimulation

Eligibility Criteria

18 Years - 90 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Single episode of unilateral, ischemic stroke in middle cerebral artery proven by means of magnetic resonance imaging or computed tomography.
  • Classification of brain injury based on the criteria: Oxfordshire Community Stroke Project (OCSP) or Trial of Org 10172 in Acute Stroke Treatment (TOAST);
  • Patients in the chronic stage (after six months after the injury)
  • Individuals over 18 years of age;
  • Both sexes;
  • Absence of mental disorders, assessed using the Self Reporting Questionnaire (SRQ-20), with a cut-off point of 7/8 points.
  • Absence of cognitive deficits, assessed using the Mini Mental State Examination (MMSE> 24).
  • Patients with mild to moderate degree of injury severity (NIHHS <17 points).

Exclusion Criteria:

  • Patients with other associated pathologies that can influence motor activity (example: traumatic brain injury, brain tumor);

    •- Participants unable to complete the initial assessment due to severe aphasia (Token Test <17);

  • habitual use of drugs or alcohol;
  • Use of drugs that modulate the activity of the Central Nervous System;
  • Gestation;
  • Use of metallic / electronic implants and / or cardiac pacemakers;

Sites / Locations

  • Federal University of Paraíba,Department of PsychologyRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

Placebo Comparator

Arm Label

Group 1 - anodal tDCS

Group 2 - tDCS dualsite

Group 3 - tDCS sham

Arm Description

Participants will receive 10 tDCS sessions, for 20 minutes, on days alternate (3 times a week). The neurostimulator TCT-Research will be used for stimulation. The electrodes will be positioned according to the international classification system of the electroencephalogram 10/20. For group 1 (anodic tDCS) the anodic electrode (5x5 cm) will be applied to the primary motor area (C3/C4) ipsilateral to the lesion and the reference electrode (6x9 cm) to the deltoid muscle region. Simultaneously with the tDCS sessions, participants will be submitted to a physical therapy protocol based on motor and cognitive dual-task training. Each task will have a duration of 3 minutes, followed by a rest period of 30s.

Participants will receive 10 tDCS sessions, for 20 minutes, on days alternate (3 times a week). The neurostimulator TCT-Research will be used for stimulation. The electrodes will be positioned according to the international classification system of the electroencephalogram 10/20. In group 2 (dualsite tDCS) two active electrodes (5x5 cm) will be used, which will be positioned over the primary motor area (C3/C4) and over the dorsolateral prefrontal cortex (F3 or F4) in the ipsilateral hemisphere. For this stimulation modality, two active electrodes (anodic) and a reference electrode (6x9 cm) will be used on the deltoid muscle region. Simultaneously with the tDCS sessions, participants will be submitted to a physical therapy protocol based on motor and cognitive dual-task training. Each task will have a duration of 3 minutes, followed by a rest period of 30s.

Participants will receive 10 tDCS sessions, for 20 minutes, on days alternate (3 times a week). The neurostimulator TCT-Research will be used for stimulation. The electrodes will be positioned according to the international classification system of the electroencephalogram 10/20. For group 3 (simulated tDCS) the positioning of the electrodes will be the same as for group 1, however the device will be configured in sham mode in which the current will cease 30 seconds after the start of stimulation. Simultaneously with the tDCS sessions, participants will be submitted to a physical therapy protocol based on motor and cognitive dual-task training. Each task will have a duration of 3 minutes, followed by a rest period of 30s.

Outcomes

Primary Outcome Measures

Fugl-Meyer assessment (FMA) pre-intervention (T0)
Fugl-Meyer assessment (FMA) for lower limbs pre-intervention (T0)
Fugl-Meyer assessment (FMA) after the stimulation protocol (T1)
Fugl-Meyer assessment (FMA) for lower limbs after the stimulation protocol (T1)

Secondary Outcome Measures

Functional connectivity (EEG) pre-intervention (T0)
The functional connectivity of the target network will be assessed, through the acquisition of the EEG
Functional connectivity (EEG) after the stimulation protocol (T1)
The functional connectivity of the target network will be assessed, through the acquisition of the EEG
EQ-5D (T0)
Quality of life. Presenting a final score from 0 to 100, where 0 corresponds to the worst general state of health and 100 the best state of health.
EQ-5D (T1)
Quality of life.Presenting a final score from 0 to 100, where 0 corresponds to the worst general state of health and 100 the best state of health.
Modified Rankin Scale pre-intervention (T0)
Functional disability. The score on the Rankin scale ranges from 0 to 6, in order to assess the patient's neurological condition, in which the higher the value, the worse the condition. 0 - No symptoms - No significant disabilities - Mild disability - Moderate disability - Moderate-severe disability - Severe disability - Death
Modified Rankin Scale after the stimulation protocol (T1)
Functional disability. The score on the Rankin scale ranges from 0 to 6, in order to assess the patient's neurological condition, in which the higher the value, the worse the condition. 0 - No symptoms - No significant disabilities - Mild disability - Moderate disability - Moderate-severe disability - Severe disability - Death
Balance
Biodex Balance System (BBS)
Balance
Biodex Balance System (BBS)
MoCA
Cognitive function
MoCA
Cognitive function

Full Information

First Posted
March 24, 2021
Last Updated
April 21, 2022
Sponsor
Federal University of Paraíba
search

1. Study Identification

Unique Protocol Identification Number
NCT04850963
Brief Title
Effects of Dualsite Anodic tDCS on Lower Limbs Function in Patients After Stroke: Randomized, Double-blind, Placebo-controlled, Crossover Trial
Official Title
Effects of Dualsite Anodic tDCS on Lower Limbs Function in Patients After Stroke
Study Type
Interventional

2. Study Status

Record Verification Date
April 2022
Overall Recruitment Status
Recruiting
Study Start Date
March 10, 2022 (Actual)
Primary Completion Date
December 24, 2022 (Anticipated)
Study Completion Date
December 24, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Federal University of Paraíba

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
It is currently known that Transcranial Direct Current Stimulation (tDCS) can modulate cortical activity, being considered an important resource in the treatment of sequelae resulting from stroke. However, evidence of the effects of tDCS on lower limb motor recovery after stroke remains scarce and inconclusive. Furthermore, little is known about the effects of dualsite tDCS in chronic patients. Therefore, the present study seeks to compare the effects of conventional anodic tDCS (M1) with double-site/dualsite anodic tDCS (M1 + DLPFC) and simulated tDCS on lower limb motor function in patients after ischemic stroke in a chronic stage. The study is a randomized, double-blind, placebo-controlled, crossover clinical trial with subjects after stroke. After recruitment and initial screening, participants will be randomized into three groups: G1: anodic tDCS - participants who will receive real current over the primary motor area; G2: dualsite tDCS - participants who will receive real current over the primary motor area and dorsolateral prefrontal area (DLPFC) and G3: simulated tDCS - participants who will receive simulated stimulation. Participants will receive 10 tDCS sessions, for 20 minutes, associated with a physical therapy protocol based on a dual motor and cognitive task, on alternate days (3 times a week). In each phase of the study, pre- and post-intervention evaluations will be carried out, the evaluated outcomes will be: motor function (Fugl-Meyer Scale), functional connectivity (EEG), quality of life (EQ-5D), level of functional disability ( Rankin Scale), static balance (Biodex Balance System) and cognitive function (MoCA). Statistical analyzes will be performed using SPSS software (Version 20.0) and MATLAB 9.2.0 with a significance level of p <0.05.
Detailed Description
Participants will be divided into 03 groups: G1: anodic tDCS - participants who will receive real current over the primary motor area; G2: dualsite tDCS - participants who will receive real current over the primary motor area and over the dorsolateral prefrontal area (DLPFC) and G3: simulated tDCS - participants who will receive simulated stimulation. Participants will be entered into the study through the eligibility criteria and will be randomly allocated, with block exchange at a rate of 1:1:1. In each phase of the study, participants will receive 10 tDCS sessions, for 20 minutes, on alternate days (3 times a week, excluding weekends). The TCT-Research neurostimulator will be used for stimulation. The electrodes will be positioned according to the 10-20 international electroencephalogram classification system. Electrodes wrapped in sponges, moistened with saline solution (0.9% NaCl) will be used. The applied current will be 2mA (5x5 cm active electrodes; 25 cm2; current density of 0.08 mA/cm2). For group 1 (anodic tDCS) the anodic electrode (5x5 cm) will be applied to the primary motor area (C3/C4) ipsilateral to the lesion and the reference electrode (6x9 cm) to the deltoid muscle region. In group 2 (dualsite tDCS) two active electrodes (5x5 cm) will be used, which will be positioned over the primary motor area (C3/C4) and over the dorsolateral prefrontal cortex (F3 or F4) in the ipsilateral hemisphere. For this stimulation modality, two active electrodes (anodic) and a reference electrode (6x9 cm) will be used on the deltoid muscle region. For group 3 (simulated tDCS) the positioning of the electrodes will be the same as for group 1, however the device will be configured in sham mode in which the current will cease 30 seconds after the start of stimulation, in this way the effects of active stimulation will be simulated and the participants will perceive the sensations typically felt, but without the induction of clinical effects (Nitsche & Paulus, 2000). At the end of each session, participants will be asked to report any unpleasant effects and asked about possible adverse effects. In addition, all participants will be blind to the type of stimulation they will receive.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke, Chronic
Keywords
Stroke, Transcranial direct current stimulation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantCare ProviderOutcomes Assessor
Allocation
Randomized
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Group 1 - anodal tDCS
Arm Type
Active Comparator
Arm Description
Participants will receive 10 tDCS sessions, for 20 minutes, on days alternate (3 times a week). The neurostimulator TCT-Research will be used for stimulation. The electrodes will be positioned according to the international classification system of the electroencephalogram 10/20. For group 1 (anodic tDCS) the anodic electrode (5x5 cm) will be applied to the primary motor area (C3/C4) ipsilateral to the lesion and the reference electrode (6x9 cm) to the deltoid muscle region. Simultaneously with the tDCS sessions, participants will be submitted to a physical therapy protocol based on motor and cognitive dual-task training. Each task will have a duration of 3 minutes, followed by a rest period of 30s.
Arm Title
Group 2 - tDCS dualsite
Arm Type
Active Comparator
Arm Description
Participants will receive 10 tDCS sessions, for 20 minutes, on days alternate (3 times a week). The neurostimulator TCT-Research will be used for stimulation. The electrodes will be positioned according to the international classification system of the electroencephalogram 10/20. In group 2 (dualsite tDCS) two active electrodes (5x5 cm) will be used, which will be positioned over the primary motor area (C3/C4) and over the dorsolateral prefrontal cortex (F3 or F4) in the ipsilateral hemisphere. For this stimulation modality, two active electrodes (anodic) and a reference electrode (6x9 cm) will be used on the deltoid muscle region. Simultaneously with the tDCS sessions, participants will be submitted to a physical therapy protocol based on motor and cognitive dual-task training. Each task will have a duration of 3 minutes, followed by a rest period of 30s.
Arm Title
Group 3 - tDCS sham
Arm Type
Placebo Comparator
Arm Description
Participants will receive 10 tDCS sessions, for 20 minutes, on days alternate (3 times a week). The neurostimulator TCT-Research will be used for stimulation. The electrodes will be positioned according to the international classification system of the electroencephalogram 10/20. For group 3 (simulated tDCS) the positioning of the electrodes will be the same as for group 1, however the device will be configured in sham mode in which the current will cease 30 seconds after the start of stimulation. Simultaneously with the tDCS sessions, participants will be submitted to a physical therapy protocol based on motor and cognitive dual-task training. Each task will have a duration of 3 minutes, followed by a rest period of 30s.
Intervention Type
Device
Intervention Name(s)
Transcranial direct current stimulation (Anodal tDCS) + dual-task training
Other Intervention Name(s)
anodal tDCS
Intervention Description
anodal tDCS 837 / 5.000 Resultados de tradução Simultaneously with the tDCS sessions, participants will be submitted to a physical therapy protocol based on motor and cognitive dual-task training, which will include: (1) walking repeating phrases spoken by the researcher; (2) walking counting numbers in ascending order; (3) walk while counting the numbers in descending order; (4) walking during the execution of a string of words; (5) Walking while listening to a list of fruits and saying "YES" when hearing the word "strawberry" and (6) walking reciting a phrase backwards. Each task will have a duration of 3 minutes, followed by a rest period of 30s. The tasks will be performed performing forward, side and back march. Subjects will be instructed to focus on both tasks. The training will have a total duration of 20 minutes in each session.
Intervention Type
Device
Intervention Name(s)
Transcranial direct current stimulation (tDCS dualsite) + dual-task traning
Other Intervention Name(s)
tDCS dualsite
Intervention Description
tDCS dualsite 837 / 5.000 Resultados de tradução Simultaneously with the tDCS sessions, participants will be submitted to a physical therapy protocol based on motor and cognitive dual-task training, which will include: (1) walking repeating phrases spoken by the researcher; (2) walking counting numbers in ascending order; (3) walk while counting the numbers in descending order; (4) walking during the execution of a string of words; (5) Walking while listening to a list of fruits and saying "YES" when hearing the word "strawberry" and (6) walking reciting a phrase backwards. Each task will have a duration of 3 minutes, followed by a rest period of 30s. The tasks will be performed performing forward, side and back march. Subjects will be instructed to focus on both tasks. The training will have a total duration of 20 minutes in each session.
Intervention Type
Device
Intervention Name(s)
Transcranial direct current stimulation sham + dual-task training
Other Intervention Name(s)
tDCS sham
Intervention Description
tDCS sham 837 / 5.000 Resultados de tradução Simultaneously with the tDCS sessions, participants will be submitted to a physical therapy protocol based on motor and cognitive dual-task training, which will include: (1) walking repeating phrases spoken by the researcher; (2) walking counting numbers in ascending order; (3) walk while counting the numbers in descending order; (4) walking during the execution of a string of words; (5) Walking while listening to a list of fruits and saying "YES" when hearing the word "strawberry" and (6) walking reciting a phrase backwards. Each task will have a duration of 3 minutes, followed by a rest period of 30s. The tasks will be performed performing forward, side and back march. Subjects will be instructed to focus on both tasks. The training will have a total duration of 20 minutes in each session.
Primary Outcome Measure Information:
Title
Fugl-Meyer assessment (FMA) pre-intervention (T0)
Description
Fugl-Meyer assessment (FMA) for lower limbs pre-intervention (T0)
Time Frame
The evaluations will be carried out in pre-intervention (T0)
Title
Fugl-Meyer assessment (FMA) after the stimulation protocol (T1)
Description
Fugl-Meyer assessment (FMA) for lower limbs after the stimulation protocol (T1)
Time Frame
The T1 assessment will be performed up to one week after the stimulation protocol is completed.
Secondary Outcome Measure Information:
Title
Functional connectivity (EEG) pre-intervention (T0)
Description
The functional connectivity of the target network will be assessed, through the acquisition of the EEG
Time Frame
The evaluations will be carried out in pre-intervention (T0)
Title
Functional connectivity (EEG) after the stimulation protocol (T1)
Description
The functional connectivity of the target network will be assessed, through the acquisition of the EEG
Time Frame
The T1 assessment will be performed up to one week after the stimulation protocol is completed.
Title
EQ-5D (T0)
Description
Quality of life. Presenting a final score from 0 to 100, where 0 corresponds to the worst general state of health and 100 the best state of health.
Time Frame
The evaluations will be carried out in pre-intervention (T0).
Title
EQ-5D (T1)
Description
Quality of life.Presenting a final score from 0 to 100, where 0 corresponds to the worst general state of health and 100 the best state of health.
Time Frame
The T1 assessment will be performed up to one week after the stimulation protocol is completed.
Title
Modified Rankin Scale pre-intervention (T0)
Description
Functional disability. The score on the Rankin scale ranges from 0 to 6, in order to assess the patient's neurological condition, in which the higher the value, the worse the condition. 0 - No symptoms - No significant disabilities - Mild disability - Moderate disability - Moderate-severe disability - Severe disability - Death
Time Frame
The evaluations will be carried out in pre-intervention (T0).
Title
Modified Rankin Scale after the stimulation protocol (T1)
Description
Functional disability. The score on the Rankin scale ranges from 0 to 6, in order to assess the patient's neurological condition, in which the higher the value, the worse the condition. 0 - No symptoms - No significant disabilities - Mild disability - Moderate disability - Moderate-severe disability - Severe disability - Death
Time Frame
The T1 assessment will be performed up to one week after the stimulation protocol is completed.
Title
Balance
Description
Biodex Balance System (BBS)
Time Frame
The T0 assessment will be performed up to one week after the stimulation protocol is completed.
Title
Balance
Description
Biodex Balance System (BBS)
Time Frame
The T1 assessment will be performed up to one week after the stimulation protocol is completed.
Title
MoCA
Description
Cognitive function
Time Frame
The T0 assessment will be performed up to one week after the stimulation protocol is completed.
Title
MoCA
Description
Cognitive function
Time Frame
The T1 assessment will be performed up to one week after the stimulation protocol is completed.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Single episode of unilateral, ischemic stroke in middle cerebral artery proven by means of magnetic resonance imaging or computed tomography. Classification of brain injury based on the criteria: Oxfordshire Community Stroke Project (OCSP) or Trial of Org 10172 in Acute Stroke Treatment (TOAST); Patients in the chronic stage (after six months after the injury) Individuals over 18 years of age; Both sexes; Absence of mental disorders, assessed using the Self Reporting Questionnaire (SRQ-20), with a cut-off point of 7/8 points. Absence of cognitive deficits, assessed using the Mini Mental State Examination (MMSE> 24). Patients with mild to moderate degree of injury severity (NIHHS <17 points). Exclusion Criteria: Patients with other associated pathologies that can influence motor activity (example: traumatic brain injury, brain tumor); •- Participants unable to complete the initial assessment due to severe aphasia (Token Test <17); habitual use of drugs or alcohol; Use of drugs that modulate the activity of the Central Nervous System; Gestation; Use of metallic / electronic implants and / or cardiac pacemakers;
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Suellen Andrade
Phone
+5583999805189
Email
suellenandrade@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Suellen Andrade
Organizational Affiliation
Federal University of Paraíba
Official's Role
Principal Investigator
Facility Information:
Facility Name
Federal University of Paraíba,Department of Psychology
City
João Pessoa
State/Province
Paraíba
ZIP/Postal Code
58051-900
Country
Brazil
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Suellen Andrade
Phone
986046032
Ext
55 83
Email
suellenandrade@gmail.com
First Name & Middle Initial & Last Name & Degree
Suellen Andrade

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Effects of Dualsite Anodic tDCS on Lower Limbs Function in Patients After Stroke: Randomized, Double-blind, Placebo-controlled, Crossover Trial

We'll reach out to this number within 24 hrs